Alzheimer's treatments: What's on the horizon?
Current Alzheimer's treatments temporarily improve symptoms of memory loss and problems with thinking and reasoning.
Nov 6, 2019
0
1
Current Alzheimer's treatments temporarily improve symptoms of memory loss and problems with thinking and reasoning.
Nov 6, 2019
0
1
Long before symptoms like memory loss even emerge, the underlying pathology of Alzheimer's disease, such as an accumulation of amyloid protein plaques, is well underway in the brain. A longtime goal of the field has been ...
Oct 4, 2019
0
284
Two years after discovering a way to neutralize a rogue protein linked to Alzheimer's disease, University of Alberta Distinguished University Professor and neurologist Jack Jhamandas has found a new piece of the Alzheimer's ...
Sep 17, 2019
0
8902
A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer's disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. ...
Sep 16, 2019
0
6
Even before a dementia diagnosis, people with mild cognitive impairment may have different changes in the brain depending on what type of dementia they have, according to a study published in the September 11, 2019, online ...
Sep 11, 2019
0
7
When researchers at the University of Kentucky compare brains donated from people who died with dementia, very rarely do they find one that bears only Alzheimer's trademark plaques and tangles—no other damage.
Sep 10, 2019
0
3
Scientists at The University of Texas at Dallas have found evidence suggesting that resistance to the "hunger hormone" ghrelin in the brain is linked to the cognitive impairments and memory loss associated with Alzheimer's ...
Sep 3, 2019
0
419
Alzheimer's disease isn't something you must either passively accept or dread, a panel of doctors and scientific experts told an audience of more than 500.
Aug 29, 2019
0
80
Many people who have problems with their memory, especially if they are elderly, worry that they have Alzheimer's disease, which afflicts at least 5.5 million people in the U.S. and brings tremendous burdens to families as ...
Aug 8, 2019
0
2
(HealthDay)—Plasma β-amyloid (Aβ)42/Aβ40 corresponds with amyloid positron emission tomography (PET) status, according to a study published online Aug. 1 in Neurology.
Aug 2, 2019
0
13